Zymeworks Inc (ZYME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 11,510 |
| Marketable Securities | 3,640 |
| Receivables | 2,260 |
| Other current assets | 260 |
| TOTAL | $17,670 |
| Non-Current Assets | |
| PPE Net | 2,130 |
| Investments And Advances | 4,180 |
| Other Non-Current Assets | 500 |
| TOTAL | $6,810 |
| Total Assets | $23,140 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 4,790 |
| Other current liabilities | 60 |
| TOTAL | $4,850 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 40 |
| TOTAL | $50 |
| Total Liabilities | $4,910 |
| Shareholders' Equity | |
| Common Shares | 83,600 |
| Retained earnings | -63,920 |
| Other shareholders' equity | -6,330 |
| TOTAL | $18,230 |
| Total Liabilities And Equity | $23,140 |